Addyi, also known as Flibanserin, was recently approved by the FDA to treat low sexual desire in women. It is the first FDA approved medication for female sexual dysfunction. Addyi is a non-hormonal oral medication, with a seemingly low side effect profile, that in essence increases dopamine and noradrenaline while reducing serotonin in the brain …
Continue Reading